Michael Doe's Album: Wall Photos
Oligonucleotide
Synthesis and Purification Services Market by Roots Analysis
The applications of
oligonucleotides are vast, even beyond the life science / pharma sector;
however, owing to complexities associated with the synthesis and processing of
these molecules, such operations are usually outsourced to capable CMOs
Roots Analysis is pleased to announce the publication of its recent study,
titled, “Oligonucleotide Synthesis,
Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic
Applications, 2020-2030.”
The report features an extensive study of the
current scenario and future potential of the custom synthesis, modification and
purification services market for oligonucleotides, which are intended for
research, diagnostic, and therapeutic applications. The study includes in-depth analyses,
highlighting the capabilities of service providers engaged in this domain. In
addition to other elements, it includes:
§ A detailed review of
the current status of the market with respect to oligonucleotide manufacturers
focused on research and diagnostic, and therapeutic applications.
§ A competitiveness
analysis of prominent oligonucleotide manufacturers, featuring insightful
pictorial summaries and representations.
§ Elaborate profiles of
key players that offer a diverse range of capabilities for custom synthesis,
modification and purification of oligonucleotides.
§ An analysis of the
various partnerships pertaining to oligonucleotide manufacturing, which have
been established in the recent past.
§ An analysis of the
various expansion initiatives undertaken by service providers engaged in this
domain.
§ A detailed analysis
of completed, ongoing and planned clinical research studies of various
oligonucleotide-based drug products.
§ An estimate of the
overall, annual capacity for manufacturing oligonucleotides based on data
reported by industry stakeholders in the public domain.
§ An informed estimate
of the annual clinical and commercial demand for oligonucleotides.
§ A discussion on
affiliated trends, key drivers and challenges, under an elaborate SWOT
framework.
§ A survey analysis
featuring inputs solicited from various experts who are directly / indirectly
involved in providing custom synthesis, modification and purification services
for oligonucleotides.
§ A detailed market
forecast, featuring analysis of the current and projected future opportunity
across key market segments (listed below)
To request for sample report - https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
Type of Manufacturing
§ Custom Manufacturing
§ Large-scale Manufacturing
Type
of Oligonucleotides Manufactured
§ Antisense Oligonucleotides
§ miRNAs
§ shRNAs
§ siRNAs
§ Other
Oligonucleotides
Scale of Operation
§ Clinical
§ Commercial
Purpose of Production
§ In-house
§ Outsourced
Target Therapeutic Area
§ Autoimmune Disorders
§ Cardiovascular Disorders
§ Genetic Disorders
§ Infectious Diseases
§ Metabolic Disorders
§ Neuromuscular Disorders
§ Oncological Disorders
§ Ophthalmic Disorders
§ Other Therapeutic Areas
Size of manufacturer
§ Small
§ Mid-sized
§ Large
Key
Geographical Region
§ North
America
§ Europe
§ Asia-Pacific and Rest
of the World
§ Transcripts of
interviews held with the following senior level representatives of stakeholder
companies
§
Joachim Bertram (Chief
Scientific Officer and Managing Director, IBA Lifesciences)
§
Tobias Pohlmann (Founder
and Managing Director, BianoScience)
Key companies covered
in the report
§
Agilent Technologies
§
Ajinomoto Bio-Pharma Services
§
BioSpring
§
CordenPharma
§
Integrated DNA Technologies
§
Kaneka Eurogentec
§
LGC Biosearch Technologies
§
Microsynth
§
Nitto Denko Avecia
§
Sigma Aldrich
§
Thermo Fisher Scientific
§
Trilink Biotechnologies
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
Other Recent Offerings
1.
China Biopharmaceutical Contract Manufacturing Market, 2020-2030
2.
Pharmaceutical Continuous Manufacturing Market, 2020-2030
3.
Peptide Therapeutics:
Contract API Manufacturing Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter
- https://twitter.com/RootsAnalysis
Synthesis and Purification Services Market by Roots Analysis
The applications of
oligonucleotides are vast, even beyond the life science / pharma sector;
however, owing to complexities associated with the synthesis and processing of
these molecules, such operations are usually outsourced to capable CMOs
Roots Analysis is pleased to announce the publication of its recent study,
titled, “Oligonucleotide Synthesis,
Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic
Applications, 2020-2030.”
The report features an extensive study of the
current scenario and future potential of the custom synthesis, modification and
purification services market for oligonucleotides, which are intended for
research, diagnostic, and therapeutic applications. The study includes in-depth analyses,
highlighting the capabilities of service providers engaged in this domain. In
addition to other elements, it includes:
§ A detailed review of
the current status of the market with respect to oligonucleotide manufacturers
focused on research and diagnostic, and therapeutic applications.
§ A competitiveness
analysis of prominent oligonucleotide manufacturers, featuring insightful
pictorial summaries and representations.
§ Elaborate profiles of
key players that offer a diverse range of capabilities for custom synthesis,
modification and purification of oligonucleotides.
§ An analysis of the
various partnerships pertaining to oligonucleotide manufacturing, which have
been established in the recent past.
§ An analysis of the
various expansion initiatives undertaken by service providers engaged in this
domain.
§ A detailed analysis
of completed, ongoing and planned clinical research studies of various
oligonucleotide-based drug products.
§ An estimate of the
overall, annual capacity for manufacturing oligonucleotides based on data
reported by industry stakeholders in the public domain.
§ An informed estimate
of the annual clinical and commercial demand for oligonucleotides.
§ A discussion on
affiliated trends, key drivers and challenges, under an elaborate SWOT
framework.
§ A survey analysis
featuring inputs solicited from various experts who are directly / indirectly
involved in providing custom synthesis, modification and purification services
for oligonucleotides.
§ A detailed market
forecast, featuring analysis of the current and projected future opportunity
across key market segments (listed below)
To request for sample report - https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
Type of Manufacturing
§ Custom Manufacturing
§ Large-scale Manufacturing
Type
of Oligonucleotides Manufactured
§ Antisense Oligonucleotides
§ miRNAs
§ shRNAs
§ siRNAs
§ Other
Oligonucleotides
Scale of Operation
§ Clinical
§ Commercial
Purpose of Production
§ In-house
§ Outsourced
Target Therapeutic Area
§ Autoimmune Disorders
§ Cardiovascular Disorders
§ Genetic Disorders
§ Infectious Diseases
§ Metabolic Disorders
§ Neuromuscular Disorders
§ Oncological Disorders
§ Ophthalmic Disorders
§ Other Therapeutic Areas
Size of manufacturer
§ Small
§ Mid-sized
§ Large
Key
Geographical Region
§ North
America
§ Europe
§ Asia-Pacific and Rest
of the World
§ Transcripts of
interviews held with the following senior level representatives of stakeholder
companies
§
Joachim Bertram (Chief
Scientific Officer and Managing Director, IBA Lifesciences)
§
Tobias Pohlmann (Founder
and Managing Director, BianoScience)
Key companies covered
in the report
§
Agilent Technologies
§
Ajinomoto Bio-Pharma Services
§
BioSpring
§
CordenPharma
§
Integrated DNA Technologies
§
Kaneka Eurogentec
§
LGC Biosearch Technologies
§
Microsynth
§
Nitto Denko Avecia
§
Sigma Aldrich
§
Thermo Fisher Scientific
§
Trilink Biotechnologies
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
Other Recent Offerings
1.
China Biopharmaceutical Contract Manufacturing Market, 2020-2030
2.
Pharmaceutical Continuous Manufacturing Market, 2020-2030
3.
Peptide Therapeutics:
Contract API Manufacturing Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
- https://twitter.com/RootsAnalysis